author-placeholder

Yale University

More from this expert

Clinical Articles iconClinical Articles

A novel form of treatment has been identified for one of the most common mental health issues globally, anxiety.Roughly one in three people will suffer from the condition at some point in their lives, experiencing irrational fear brought on by stressors ranging from spiders to public speaking.Current treatment options are limited. Some medications provide relief, but can also cause side effects. Cognitive behavioural therapy can also be used, typically exposure-based therapies that allow patients to gradually face and overcome their fears. But for a substantial proportion of sufferers, these options are not effective.

A novel form of treatment has been identified for one of the most common mental health issues globally, anxiety.Roughly one in three people will suffer from the condition at some point in their lives, experiencing irrational fear brought on by stressors ranging from spiders to public speaking.Current treatment options are limited. Some medications provide relief, but can also cause side effects. Cognitive behavioural therapy can also be used, typically exposure-based therapies that allow patients to gradually face and overcome their fears. But for a substantial proportion of sufferers, these options are not effective.

Clinical Articles iconClinical Articles

Upcoming Healthed Webcast

Panel discussion on GLP1s for chronic kidney disease in type 2 diabetes

TONIGHT Tuesday 28th October, 7pm - 9pm AEDT

Panellists

Prof Genie Pedagogos, Prof Richard MacIsaac & A/Prof Ralph Audehm

Paediatric Allergist and Immunologist; Royal Children's Hospital

We invite you to our next free webcast, where an expert panel will discuss GLP1s for CKD in T2D. Up to 4 hours CPD. RACGP & ACRRM accredited.